Phenotype
|
Fish
|
Conditions
|
Figures
|
whole organism 11-oxotestosterone decreased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 2
from Wang et al., 2021
|
ovary casp9 expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 5
from Wang et al., 2021
|
testis apoptotic process increased occurrence, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 5
from Wang et al., 2021
|
testis hypertrophic, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 2
from Wang et al., 2021
|
Sertoli cell gsdf expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
Leydig cell cyp11c1 expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
male gonad development increased occurrence, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 5
from Wang et al., 2021
|
spermatid differentiation disrupted, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 3
from Wang et al., 2021
|
whole organism estradiol decreased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 2
from Wang et al., 2021
|
testis hsd3b1 expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
whole organism cortisol decreased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 2
from Wang et al., 2021
|
whole organism 11-Ketoandrosterone decreased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 2
from Wang et al., 2021
|
testis nanos2 expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 6
from Wang et al., 2021
|
oogenesis arrested, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 4
from Wang et al., 2021
|
urogenital papilla protruding, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 2
from Wang et al., 2021
|
spermatocyte increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 3
from Wang et al., 2021
|
testis cyp19a1a expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
sperm amount, ameliorated
|
cyp11a1.2ihb317/ihb317 (AB)
|
chemical treatment by environment: pregnenolone
|
Fig. 5
from Wang et al., 2021
|
anal fin light yellow, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 2
from Wang et al., 2021
|
testis cyp11a1.2 expression decreased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 1
from Wang et al., 2021
|
testis gdf9 expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
Leydig cell insl3 expression decreased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
testis inha expression decreased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
testis bmp15 expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
female gonad development decreased occurrence, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 5
from Wang et al., 2021
|
whole organism male with DSD, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 2
from Wang et al., 2021
|
Sertoli cell amh expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
ovary tp53 expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 5
from Wang et al., 2021
|
spermatogenic cyst decreased area, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 5
from Wang et al., 2021
|
testis sycp3 expression decreased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 6
from Wang et al., 2021
|
spermatogonium increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 3,
Fig. 6
from Wang et al., 2021
|
testis igf3 expression decreased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
female sex determination absent process, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 2,
Fig. 4
from Wang et al., 2021
|
gonad increased weight, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 2
from Wang et al., 2021
|
testis ddx4 expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 6
from Wang et al., 2021
|
whole organism progesterone decreased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 2
from Wang et al., 2021
|
sperm decreased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 3,
Fig. 5
from Wang et al., 2021
|
spermatogenic cyst area, ameliorated
|
cyp11a1.2ihb317/ihb317 (AB)
|
chemical treatment by environment: pregnenolone
|
Fig. 5
from Wang et al., 2021
|
testis cyp17a1 expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
testis sox9b expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
testis star expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
female gonad development normal occurrence, ameliorated
|
cyp11a1.2ihb317/ihb317 (AB)
|
chemical treatment by environment: pregnenolone
|
Fig. 5
from Wang et al., 2021
|
testis cell diploid, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 3
from Wang et al., 2021
|
female gonad development decreased occurrence, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
chemical treatment by environment: estradiol
|
Fig. 5
from Wang et al., 2021
|
testis gsdf expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
testis cimap1b expression decreased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 6
from Wang et al., 2021
|
male gonad development increased occurrence, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
chemical treatment by environment: estradiol
|
Fig. 5
from Wang et al., 2021
|
male organism decreased fecundity, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 3
from Wang et al., 2021
|
testis insl3 expression decreased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
whole organism testosterone decreased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 2
from Wang et al., 2021
|
spermatid decreased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 3
from Wang et al., 2021
|
male gonad development normal occurrence, ameliorated
|
cyp11a1.2ihb317/ihb317 (AB)
|
chemical treatment by environment: pregnenolone
|
Fig. 5
from Wang et al., 2021
|
testis cell population proliferation increased occurrence, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 6
from Wang et al., 2021
|
Sertoli cell inha expression absent, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
spermatogenesis disrupted, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 3
from Wang et al., 2021
|
testis cyp11c1 expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
testis amh expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
Leydig cell cyp17a1 expression increased amount, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 7
from Wang et al., 2021
|
testis cyp11a1.2 expression absent, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 1
from Wang et al., 2021
|
whole organism androst-4-ene-3,17-dione absent, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 2
from Wang et al., 2021
|
male mating behavior disrupted, abnormal
|
cyp11a1.2ihb317/ihb317 (AB)
|
standard conditions
|
Fig. 3
from Wang et al., 2021
|